House Republicans have issued a subpoena for WilmerHale partner Ronald Machen, an attorney for ActBlue, demanding his testimony regarding discrepancies in the Democratic fundraising platform’s foreign donor screening practices. The request was made in a letter sent Monday by House Judiciary Committee Chairman Jim Jordan (R-OH), House Administration Committee Chairman Bryan Steil (R-WI), and House Oversight Committee Chairman James Comer (R-KY).
The subpoena follows a September 11, 2026 briefing in which Machen provided information to House committees investigating ActBlue’s donor verification processes. Republicans allege that Machen’s statements appear to contradict internal data on ActBlue’s standards for ensuring donors are U.S. citizens. The letter to Machen states that his review of the platform’s practices may have been an attempt to "sugarcoat" prior misrepresentations by ActBlue CEO Regina Wallace-Jones, who invoked her Fifth Amendment rights 22 times during a June 10 congressional interview.
ActBlue, a major Democratic fundraising platform used by figures such as Rep. Alexandria Ocasio-Cortez (D-NY) and Senate Majority Leader Chuck Schumer (D-NY), has faced ongoing scrutiny from Republicans over its donor verification procedures. The company has previously stated that it has strengthened its screening processes in response to the GOP’s investigation. The subpoena requires Machen to appear for a closed-door transcribed interview before October 9, 2026.
Background: The Investigation’s Origins
The House GOP’s probe into ActBlue began amid allegations that the platform had lax verification standards allowing foreign donations to flow into Democratic campaigns. Republicans have long criticized ActBlue’s practices, arguing that the platform’s screening methods are insufficient to prevent foreign interference. ActBlue has denied these claims, asserting that it complies with all federal election laws and has implemented additional safeguards in recent months.
Republican Allegations and Legal Basis
The GOP’s letter to Machen cites concerns that his review of ActBlue’s donor processes may have been an attempt to retroactively justify prior statements by Wallace-Jones, who testified before Congress in June. During that hearing, Wallace-Jones repeatedly invoked the Fifth Amendment, declining to answer questions about passport collection and donor outreach. Republicans have framed this as evidence of potential misconduct, suggesting that ActBlue’s practices may have obscured the true origins of some donations.
ActBlue’s Response and Policy Changes
ActBlue has maintained that its donor verification processes are robust and compliant with federal regulations. In a statement, the company noted that it has enhanced its screening protocols since the start of the GOP’s investigation, including additional identity verification measures for high-value donations. ActBlue has also emphasized that it has no evidence of foreign donations being accepted through its platform.
The subpoena for Machen marks the latest escalation in the House GOP’s investigation, which has already seen multiple ActBlue executives refuse to testify or invoke their Fifth Amendment rights. The outcome of Machen’s testimony could influence the direction of the probe and potential legislative or regulatory actions targeting ActBlue’s operations.